FBP2
Basic information
Region (hg38): 9:94558720-94593824
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, childhood-onset, remitting | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic | 33977262 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 3 |
Variants in FBP2
This is a list of pathogenic ClinVar variants found in the FBP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-94558939-T-C | Benign (Dec 31, 2019) | |||
9-94558959-C-G | not specified | Uncertain significance (Oct 13, 2023) | ||
9-94559033-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
9-94559042-C-A | not specified | Uncertain significance (Sep 01, 2021) | ||
9-94559063-C-G | not specified | Uncertain significance (Mar 18, 2024) | ||
9-94559122-A-G | Likely benign (Jul 01, 2024) | |||
9-94559128-C-A | not specified | Uncertain significance (Mar 18, 2024) | ||
9-94563388-C-G | not specified | Uncertain significance (Mar 06, 2023) | ||
9-94563421-A-G | not specified | Uncertain significance (Dec 06, 2023) | ||
9-94567300-A-G | Benign (Dec 31, 2019) | |||
9-94567340-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
9-94567343-C-T | not specified | Benign (Jan 06, 2020) | ||
9-94567349-A-G | not specified | Uncertain significance (Apr 12, 2024) | ||
9-94571466-T-A | not specified | Uncertain significance (Jun 02, 2024) | ||
9-94571473-T-C | not specified | Uncertain significance (May 15, 2024) | ||
9-94571484-A-T | not specified | Uncertain significance (Oct 05, 2022) | ||
9-94571485-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
9-94571520-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
9-94571525-G-A | Likely benign (Jan 01, 2023) | |||
9-94584606-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
9-94584660-C-T | Leukodystrophy, childhood-onset, remitting | Uncertain significance (Mar 01, 2024) | ||
9-94584662-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
9-94587330-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
9-94587383-A-G | Benign (Nov 01, 2023) | |||
9-94587429-C-G | not specified | Uncertain significance (Apr 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBP2 | protein_coding | protein_coding | ENST00000375337 | 7 | 35074 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000221 | 0.922 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.190 | 201 | 209 | 0.963 | 0.0000124 | 2172 |
Missense in Polyphen | 65 | 75.015 | 0.8665 | 787 | ||
Synonymous | 0.0346 | 92 | 92.4 | 0.995 | 0.00000626 | 704 |
Loss of Function | 1.59 | 8 | 14.5 | 0.550 | 6.95e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000453 | 0.000453 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000791 | 0.0000791 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations and probably participates in glycogen synthesis from carbohydrate precursors, such as lactate. {ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18214967}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Pentose phosphate pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Glycolysis and Gluconeogenesis;Metabolism of carbohydrates;Fructose Mannose metabolism;Glycolysis Gluconeogenesis;Metabolism;Pentose phosphate cycle;gluconeogenesis;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.233
Intolerance Scores
- loftool
- 0.462
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.46
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- N
- hipred_score
- 0.410
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.981
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbp2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype;
Gene ontology
- Biological process
- sucrose biosynthetic process;fructose metabolic process;fructose 6-phosphate metabolic process;gluconeogenesis;dephosphorylation;fructose 1,6-bisphosphate metabolic process
- Cellular component
- nucleoplasm;cytoplasm;cytosol;plasma membrane;Z disc;cell junction;extracellular exosome
- Molecular function
- protein binding;fructose 1,6-bisphosphate 1-phosphatase activity;identical protein binding;metal ion binding